Navigation Links
Dr Reddy’s Laboratories to challenge patents on drug

Pharma major Dr Reddy’s Laboratories will continue to aggressively challenge patents on drugs in the US despite the recent denial of a 180-day marketing exclusivity to its generic Omeprazole 40 mg capsules by the US Food and Drug Administration. Omeprazole is indicated for the treatment of duodenal and gastric ulcers.

The FDA granted the marketing exclusivity to Andrx group of the US. The loss of marketing exclusivity is a setback for Dr Reddy’s, but this will be temporary. This is to be expected in the game of patent challenges but since generic drugs provide an enormous opportunity, Dr Reddy’s Laboratories will continue to aggressively challenge the patents on other drugs.//

Apart from generic drug challenges, Dr Reddy’s Laboratories is also focusing on patent generic drugs, innovative drug deliveries and drugs which are difficult to formulate. Nothing can be as profitable as a generic drug, because of the manufacturing cost advantage. In fact, the marketing exclusivity on fluoxetine is the best thing to have happened to Dr Reddy’s in a very long time.

The next generic drug which Dr Reddy’s hopes to launch in the US is Ciprofloxacin, on which Bayer AG has a patent till December 2003. Other generic drugs in Dr Reddy’s pipeline are Olanzapine, on which Eli Lilly has a patent, and Ondansetron, on which Glaxo SmithKline Beecham has the patent, but these will be in 204.
'"/>




Page: 1

Related medicine news :

1. Dr Reddy’s Laboratories launches Hyalosy
2. Dr Reddy’s Strikes Deal With Rheoscience For Type 2 Diabetes Dru
3. Dr Reddy’s Laboratories launches Hyalosy
4. AAI Pharma Files Lawsuit Against Dr. Reddys Laboratories
5. Abbott Laboratories to buy Biocompatibles cardiovascular stent business
6. Abbott’s Laboratories R&D Capabilities Questione
7. Ranbaxy Laboratories All Set To Export Bird Flu Vaccines
8. ICMR to Set up Laboratories to Combat Bird Flu
9. Ranbaxy Laboratories to Be Aided in Drug Research
10. Bangladesh to Set Up HIV/AIDS Diagnosis Laboratories
11. Finding relief from Excruciating Headaches a challenge
Post Your Comments:
(Date:10/7/2008)...oduces Color Me Healthy(TM)/Salud Primero to teach...ulum, BENSENVILLE, Ill., Oct. 7 /PRNewswire/ -- L...pansive campaign to bring a comprehensive diet and... Early Head Start,classrooms in an effort to have ...d diabetes in minority children. Lifelink also wil...
(Date:10/7/2008)...w! Everything a Man Wanted to Know But Was Afraid ...e are 4.3 million babies born,in the U.S. each yea...ntil,now. BEING DAD is a revealing, entertaining a... and experiences for dads-to-be from fathers who,h...ry process. It includes,a wealth of advice from se...
(Date:10/7/2008)...aged individuals show signs of awareness, unlike v...lthDay News) -- Severely brain-damaged patients i...n and require painkilling treatment, according to ...state (MCS) is different than a persistent vegetat...t awareness of self or surroundings. MCS patients ...
(Date:10/7/2008)... Oct. 7 /PRNewswire-USNewswire/ -- The Catholic He...conjunction with Catholic,Health Initiatives (CHI)...and Trinity Health, Novi, MI -- is launching a min...climate change., Through receipt of a $20,000 gra... Environment (NRPE) and the Catholic Coalition on,...
Breaking Medicine News(10 mins):Health News:DuPage's Only Provider of Head Start Takes Aim at Childhood Obesity in Minorities 2Health News:DuPage's Only Provider of Head Start Takes Aim at Childhood Obesity in Minorities 3Health News:BEING DAD DVD Offers a Sneak Peek at Pregnancy From a Guy's Point of View 2Health News:Patients in Minimally Conscious State May Still Feel Pain 2Health News:Catholic Health Organizations Launch Ministry-Wide Effort to Raise Awareness About Global Climate Change 2
...r, from the tender age of 4, known widely for his ...ck to his health. No, this was not an accidental f... On Thursday, Mr Diomande collapsed soon after a ...is due to inhalation of anthrax spores. This might...
...mportant position on the National Health Service’s...t month. The obvious reason, clinics in Britain ar...ransmitted diseases. // During a recent survey co... of facilities available, almost one in three doc...
...able-pants' heart failure therapy lack of conclusi...hat too little evidence exists to support a device...eart failure. // The technique in question is cal...a noninvasive therapy to improve blood flow to the...
...Government to distribute subsidized life-saving he... hepatitis C infected patients in Australia. // A...0) currently receive treatment for their condition...earliest, Australia might soon witness a rapid ris...
Other Medicine News:Health News:'Inflatable-pants' heart failure therapy suffers due to lack of evidence. 2
(Date:10/7/2008)...UVER, Oct. 7 / Burcon Nutra...at its Puratein(R) and,Supertein(TM) canola protei... for their intended use in a variety of food and b...affirmed GRAS through an,independent evaluation by...d safety, toxicology, nutritional sciences, food a...
(Date:10/7/2008)...- Data Presented Today at ACG Annual Scientific Me...all/ -- Ironwood,Pharmaceuticals, Inc. (formerly M...: FRX ) today announced the presentation of resul...afety and efficacy in 420 patients with,irritable ... of the data,indicates that once- daily oral dosin...
(Date:10/7/2008)...IEGO, Oct. 7 /- Ardea Biosc... a poster entitled "RDEA119, a Potent,and Highly S... Sulfate,Sodium (DSS) -- induced Chronic Colitis i...Gastroenterology (ACG) 2008 Annual Meeting in Orla... a preclinical study of,RDEA119, the Company,s lea...
(Date:10/6/2008)...ETON, N.J., Oct. 6 /- Pharm...d E.T. Smith, Ph.D., is joining the,Company as Vic...mmunications. Dr. Smith will be responsible for al...ectly to Chief Financial Officer Kurt,Leutzinger.,...d Senior Biotechnology,Analyst at JPMorgan Securit...
Breaking Medicine Technology:Burcon announces GRAS status for Puratein(R) & Supertein(TM) 2Burcon announces GRAS status for Puratein(R) & Supertein(TM) 3Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 2Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 3Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 4Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 5Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 2Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 3Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 4Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications 2Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications 3Wildwood Organics Introduces Probiotic Soymilk 28TM 29 13990 1Wildwood Organics Introduces Probiotic Soymilk 28TM 29 13990 2The Disappearing Toothbrush 3A Survey Reveals Kids Top Excuses to Avoid Brushing 13988 1The Disappearing Toothbrush 3A Survey Reveals Kids Top Excuses to Avoid Brushing 13988 2The Disappearing Toothbrush 3A Survey Reveals Kids Top Excuses to Avoid Brushing 13988 3The Disappearing Toothbrush 3A Survey Reveals Kids Top Excuses to Avoid Brushing 13988 4Open Biosystems Open Access RNAi Program Adopted by Harvard Medical School and University of North Carolina 3848 1Open Biosystems Open Access RNAi Program Adopted by Harvard Medical School and University of North Carolina 3848 2Los Angeles Finest Restaurants Wineries and Chefs Gather in Support of Sexual Health and Rights 13987 1Los Angeles Finest Restaurants Wineries and Chefs Gather in Support of Sexual Health and Rights 13987 2
...pr 26, 2007 - Aeolus,Pharmaceuticals, Inc. (OTCBB:...l 18, 2007 issue of the Journal of Neuroscience a ... and National Jewish,Medical and Research Center d...able catalytic antioxidant, AEOL 11207, demonstrat...,s disease ("PD").,The study also showed that the ...
...ess of Hypertension,Treatment Valsartan in Prevent...KYO, April 26, 2007 /Xinhua-PRNewswire/ -- The cli...-scale clinical trial,headed by the Jikei Universi...internationally renowned medical journal The,Lance...is one of,the largest cardiovascular intervention ...
Other Medicine Technology:Study Demonstrating Aeolus Compound's Neuroprotection in,Parkinson's Disease Published in the Journal of Neuroscience 2Study Demonstrating Aeolus Compound's Neuroprotection in,Parkinson's Disease Published in the Journal of Neuroscience 3First Controlled Large-Scale Intervention Angiotensin Receptor,Blocker (ARB) Trial in a Japanese Population, JIKEI HEART Study,Demonstrates Significant Reduction in Blood Pressure and Protection,of Organs with Valsartan 2First Controlled Large-Scale Intervention Angiotensin Receptor,Blocker (ARB) Trial in a Japanese Population, JIKEI HEART Study,Demonstrates Significant Reduction in Blood Pressure and Protection,of Organs with Valsartan 3First Controlled Large-Scale Intervention Angiotensin Receptor,Blocker (ARB) Trial in a Japanese Population, JIKEI HEART Study,Demonstrates Significant Reduction in Blood Pressure and Protection,of Organs with Valsartan 4
Dual-sided, Interhemispheric Grid Electrode with 16 Contact Leads; Cortical Grid Electrode with 16 Contact Leads; Pediatric Grid Electrode with Flex Connector, 0.5 cm spacing
.... Gates and Mary E. Dunn at the Minnesota Epilepsy...iability, safety and ease of use. For cortical str...ted flush with the electrode surface, are individu... depth electrodes are fitted with a gold plated mi...
...you with an alternative method for monitoring epil...n as Ad-Techs Spencer Probe Depth Electrodes, exce...e instead of a stylet. Features include a smaller ... contacts, 5.0 mm standard contact spacing, and de...
...r controlled tissue modification in small joint ap...leable tip, controlled capsuloligamentous or tendi...ieved. When used in conjunction with the OPES Elec...eal time tissue impedance tracking allows the,OP...
Medicine Products: